These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2555276)

  • 1. Redox cycling in MCF-7 human breast cancer cells by antitumor agents based on mitozantrone.
    Fisher GR; Brown JR; Patterson LH
    Free Radic Res Commun; 1989; 7(3-6):221-6. PubMed ID: 2555276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of hydroxyl radical formation and DNA strand breakage in the cytotoxicity of anthraquinone antitumour agents.
    Fisher GR; Brown JR; Patterson LH
    Free Radic Res Commun; 1990; 11(1-3):117-25. PubMed ID: 1963615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for human liver mediated free-radical formation by doxorubicin and mitozantrone.
    Basra J; Wolf CR; Brown JR; Patterson LH
    Anticancer Drug Des; 1985 Oct; 1(1):45-52. PubMed ID: 2835961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of involvement of reactive oxygen in the cytotoxicity of mitoxantrone, CI941 and ametantrone in MCF-7 cells: comparison with doxorubicin.
    Fisher GR; Patterson LH
    Cancer Chemother Pharmacol; 1992; 30(6):451-8. PubMed ID: 1394801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The toxicity of menadione and mitozantrone in human liver-derived Hep G2 hepatoma cells.
    Duthie SJ; Grant MH
    Biochem Pharmacol; 1989 Apr; 38(8):1247-55. PubMed ID: 2539822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of iron from ferritin storage by redox cycling of stilbene and steroid estrogen metabolites: a mechanism of induction of free radical damage by estrogen.
    Wyllie S; Liehr JG
    Arch Biochem Biophys; 1997 Oct; 346(2):180-6. PubMed ID: 9343364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the anthrapyrazole antitumour agent CI941 on rat liver microsome and cytochrome P-450 reductase mediated free radical processes. Inhibition of doxorubicin activation in vitro.
    Graham MA; Newell DR; Butler J; Hoey B; Patterson LH
    Biochem Pharmacol; 1987 Oct; 36(20):3345-51. PubMed ID: 2823819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for enzymatic activation and oxygen involvement in cytotoxicity and antitumor activity of N,N',N''-triethylenethiophosphoramide.
    Teicher BA; Waxman DJ; Holden SA; Wang YY; Clarke L; Alvarez Sotomayor E; Jones SM; Frei E
    Cancer Res; 1989 Sep; 49(18):4996-5001. PubMed ID: 2504483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of the minor groove-binder U73-975 or the intercalator mitoxantrone with antitumor alkylating agents in MCF-7 or MCF-7/CP cells.
    Ayash L; Korbut T; Herman TS; Teicher BA
    Cancer Lett; 1991 Dec; 61(1):7-14. PubMed ID: 1764699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of doxorubicin, epirubicin and mitozantrone as single agents in advanced breast carcinoma.
    Lawton PA; Spittle MF; Ostrowski MJ; Young T; Madden F; Folkes A; Hill BT; MacRae K
    Clin Oncol (R Coll Radiol); 1993; 5(2):80-4. PubMed ID: 8481365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-mitozantrone monoclonal antibody NO-1, protects acute leukaemia cell lines from the cytotoxic effects of mitozantrone.
    Flavell SU; Flavell DJ
    Br J Haematol; 1991 Jul; 78(3):330-3. PubMed ID: 1873218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-protein conjugates--XIV. Mechanisms of formation of protein-arylating intermediates from amodiaquine, a myelotoxin and hepatotoxin in man.
    Maggs JL; Tingle MD; Kitteringham NR; Park BK
    Biochem Pharmacol; 1988 Jan; 37(2):303-11. PubMed ID: 3342086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity and superoxide anion generation by some naturally occurring quinones.
    Johnson Inbaraj J; Gandhidasan R; Murugesan R
    Free Radic Biol Med; 1999 May; 26(9-10):1072-8. PubMed ID: 10381175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitozantrone-induced toxicity and DNA strand breaks in leukaemic cells.
    Ho AD; Seither E; Ma DD; Prentice HG
    Br J Haematol; 1987 Jan; 65(1):51-5. PubMed ID: 3468998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual NAD(P)H-dependent O2-.-enerating redox system in hepatoma 22a nuclei.
    Peskin AV; Konstantinov AA; Zbarsky IB
    Free Radic Res Commun; 1987; 3(1-5):47-55. PubMed ID: 2854529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-mutagenicity relationship among aminoquinolines, aza-analogues of naphthylamine, and their N-acetyl derivatives.
    Takahashi K; Kaiya T; Kawazoe Y
    Mutat Res; 1987 Apr; 187(4):191-7. PubMed ID: 3550446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of verapamil on the anti-tumour action of mitozantrone and doxorubicin against renal carcinoma cells in vitro.
    Lai T; Morgan AP; Smith PJ; Symes MO
    Br J Urol; 1990 Dec; 66(6):596-601. PubMed ID: 2265330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of P450IIE1 in the metabolism of 3-hydroxypyridine, a constituent of tobacco smoke: redox cycling and DNA strand scission by the metabolite 2,5-dihydroxypyridine.
    Kim SG; Novak RF
    Cancer Res; 1990 Sep; 50(17):5333-9. PubMed ID: 2167153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen-dependent hepatotoxicity due to doxorubicin: role of reducing equivalent supply in perfused rat liver.
    Ganey PE; Kauffman FC; Thurman RG
    Mol Pharmacol; 1988 Nov; 34(5):695-701. PubMed ID: 3193959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic studies of the effect of Cu (II) on oxygen radical production stimulated by daunorubicin and ametantrone.
    Tarasiuk J; Kolodziejczyk P; Borowski E
    Biochem Pharmacol; 1990 May; 39(9):1405-10. PubMed ID: 2159304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.